News for Sight Sciences, Inc. (SGHT)

Citigroup analyst Joanne Wuensch has maintained a "Neutral" rating for Sight Sciences (SGHT), while also raising the price target for the company. The updated p

Citi has adjusted its price target for Sight Sciences (SGHT), increasing it to $3.60 from the previous $3.20, while maintaining a Neutral stance on the shares.

Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2025 Earnings Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsHannah Jefferies - Investor RelationsPaul...

In recent developments for Sight Sciences (SGHT), analyst Frank Takkinen from Lake Street has maintained his 'Hold' rating for the company. Despite retaining th

Lake Street has increased its price target for Sight Sciences (SGHT), moving it up to $3 from a previous $2.50, while maintaining a Hold rating on the stock. Th

Release Date: May 08, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Sight Sciences In

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NSGHT.OQ - Sight Sciences IncQ1 2025 Sight Sciences Inc Earnings CallMay 08, 2025 / 08:30PM GMT

While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sight Sciences (SGHT) has announced that its Surgical Glaucoma segment is likely to face financial pressures due to tariffs imposed by the U.S. on Chinese impor

The company has revised its financial outlook, considering the implications of new Medicare Local Coverage Determinations (LCDs) that took effect in November 20

Sight Sciences, Inc. (SGHT) reported a first-quarter revenue of $17.5 million, surpassing the expected $16.51 million. The company remains dedicated to supporti

MENLO PARK, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. ( SGHT), an eyecare technology company focused on developing and commercializing inn

Sight Sciences (SGHT) delivered earnings and revenue surprises of 3.45% and 5.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. ( SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on

**media[602242]**

Australia-based Innovation Beverage Group Limited (IBG) is up over 192 percent in Wednesday's pre-market trading. The following are some of the other stocks making big moves in Wednesday's pre-market trading.

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2024 Earnings Conference Call March 5, 2025 4:30 PM ETCompany ParticipantsPhilip Trip Taylor - IRPaul Badawi -...

While the top- and bottom-line numbers for Sight Sciences (SGHT) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Sight Sciences (SGHT) delivered earnings and revenue surprises of -15% and 0.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?